全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

Beneficial Effects of Adalimumab Counteracted in Patient with Common Variable Immunodeficiency Disorder (CVID) Receiving IVIG: Case Report

DOI: 10.1016/j.jaci.2016.12.025

Full-Text   Cite this paper   Add to My Lib

Abstract:

Adalimumab is a monoclonal antibody (mAb) against TNF alpha used to treat rheumatoid arthritis (RA). Despite prevalence of autoimmune disease in CVID, there are no published cases of negative interactions between IVIG and adalimumab.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133